Vivanza Biosciences Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 0.19 | 0.77 | 1.59 |
| Operating Expense | 1.07 | 0.64 | 1.48 |
| Net Profit | -0.97 | 0.04 | 0.01 |
| Net Profit Margin | -510.53 | 5.19 | 0.63 |
| Earning Per Share | -0.24 | 0.01 | TBA |
| EBIDTA | -0.89 | 0.13 | 0.10 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 0.19 |
| Operating Expense | 1.07 |
| Net Profit | -0.97 |
| Net Profit Margin | -510.53 |
| Earning Per Share | -0.24 |
| EBIDTA | -0.89 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 14.41 | 14.21 | 9.15 |
| Operating Expenses Annual | 13.61 | 13.49 | 9.10 |
| Operating Profit Annual | 0.85 | 1.11 | 0.88 |
| Interest Annual | 0.41 | 0.42 | 0.41 |
| Depreciation | 0.01 | 0.00 | 0.01 |
| Net Profit Annual | 0.32 | 0.57 | 0.46 |
| Tax Annual | 0.11 | 0.12 | 0.00 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 14.41 |
| Operating Expenses Annual | 13.61 |
| Operating Profit Annual | 0.85 |
| Interest Annual | 0.41 |
| Depreciation | 0.01 |
| Net Profit Annual | 0.32 |
| Tax Annual | 0.11 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.10 | 0.02 | 0.05 |
| Cash Flow from Operations | 1.78 | 0.16 | -0.68 |
| Cash Flow from Investing | -0.04 | TBA | TBA |
| Cash Flow from Financing | -1.76 | -0.08 | 0.65 |
| Cash Flow at the End | 0.09 | 0.10 | 0.02 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.10 |
| Cash Flow from Operations | 1.78 |
| Cash Flow from Investing | -0.04 |
| Cash Flow from Financing | -1.76 |
| Cash Flow at the End | 0.09 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 5.97 | 7.88 | 9.84 |
| PBIT Margin (%) | 5.90 | 7.88 | 9.73 |
| PBT Margin (%) | -8.12 | -10.42 | -12.89 |
| Net PROFIT Margin (%) | 2.22 | 4.01 | 5.03 |
| Return On Networth / Equity (%) | 7.02 | 13.57 | 11.50 |
| Return On Networth /Employed (%) | 8.98 | 11.56 | 14.13 |
| Return On Assets (%) | 3.38 | 5.94 | 7.79 |
| Total Debt / Equity (X) | 1.08 | 1.33 | 0.64 |
| Asset Turnover Ratio (%) | 1.52 | 1.48 | 1.55 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 5.97 |
| PBIT Margin (%) | 5.90 |
| PBT Margin (%) | -8.12 |
| Net PROFIT Margin (%) | 2.22 |
| Return On Networth / Equity (%) | 7.02 |
| Return On Networth /Employed (%) | 8.98 |
| Return On Assets (%) | 3.38 |
| Total Debt / Equity (X) | 1.08 |
| Asset Turnover Ratio (%) | 1.52 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 0.03 | 0.00 | 0.00 |
| Total Current Assets Annual | 14.33 | 17.93 | 11.70 |
| Non Current Assets Annual | 2.54 | 2.51 | 2.51 |
| Total Shareholders Funds Annual | 4.72 | 4.40 | 3.83 |
| Total Assets Annual | 16.87 | 20.44 | 14.21 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 0.03 |
| Total Current Assets Annual | 14.33 |
| Non Current Assets Annual | 2.54 |
| Total Shareholders Funds Annual | 4.72 |
| Total Assets Annual | 16.87 |
EPS (INR)
Expected
0.00
Reported
-0.25
Surprise
0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
Jun 2024
EPS beaten by -100.00%
